Professional Documents
Culture Documents
848 Emerging Infectious Diseases www.cdc.gov/eid Vol. 12, No. 5, May 2006
Human Bocavirus Infection, Canada
Conclusions
Although a causal relationship still needs to be demon-
strated by including a control group of healthy persons,
detection of HBoV in respiratory tract specimens from
patients with undiagnosed ARI suggests that this virus may
be associated with respiratory illness. This finding sup-
ports those of Allander et al. with regard to the association
of HBoV with respiratory disease (1). It also demonstrates
that HBoV was present in Canada in 2003 and 2004, which
suggests that it may be circulating worldwide. Since this
study used only samples from ARI patients who tested
negative for influenza viruses A and B, parainfluenza
viruses 13, adenovirus, RSV, and HMPV, dual infection
cannot be excluded. In addition, whether HBoV is present
asymptomatically in humans cannot be excluded because
samples from healthy persons were not tested.
Allander et al. reported HBoV only in infants and chil-
dren, which was probably the result of testing fewer spec-
imens from adults patients (1). Most respiratory viruses
show a seasonal distribution with peak activity in winter.
Human parvovirus B19, the only parvovirus that is patho-
genic in humans, is also seasonal, with peak occurrences in
spring and summer (3). In contrast, no seasonal prevalence
pneumonia (3/3) and half of those with bronchiolitis (1/2) was observed for HBoV infection; the virus was found
were also in this age group. throughout the year. The lack of seasonality observed for
Nucleotide sequences were determined for nucleotides HBoV may have been caused by the low prevalence in this
23422581 that encode the NP-1 gene of HBoV (GenBank study. Thus, additional year-round studies are needed to
accession nos. DQ267760DQ267775). No differences in better understand the epidemiology of HBoV. Most (89%)
nucleic acid sequences were found between different hospitalizations were in persons <5 years of age, which
Emerging Infectious Diseases www.cdc.gov/eid Vol. 12, No. 5, May 2006 849
DISPATCHES
suggests that HBoV may cause more severe respiratory ill- 6. Bastien N, Ward D, van Caeseele P, Brandt K, Lee SH, McNabb G, et
ness in infants and children, similar to disease caused by al. Human metapneumovirus infection in the Canadian population. J
Clin Microbiol. 2003;41:46426.
RSV (4,5), HMPV (6,7), human coronavirus NL63 (814), 7. Esper F, Martinello RA, Boucher D, Weibel C, Ferguson D, Landry
and human coronavirus 229E (15). More comprehensive ML, et al. A 1-year experience with human metapneumovirus in chil-
studies with data on prevalence, risk factors, and use of dren aged <5 years. J Infect Dis. 2004;189:138896.
health services are needed to determine the role of HBoV 8. Arden KE, Nissen MD, Sloots TP, Mackay IM. New human coron-
avirus, HCoV-NL63, associated with severe lower respiratory tract
in ARI and its effect on the healthcare system. disease in Australia. J Med Virol. 2005;75:45562.
9. Bastien N, Anderson K, Hart L, van Caeseele P, Brandt K, Milley D,
et al. Human coronavirus NL63 infection in Canada. J Infect Dis.
This study was supported by the Public Health Agency of 2005;191:5036.
Canada. 10. Chiu SS, Chan KH, Chu KW, Kwan SW, Guan Y, Poon LL, et al.
Human coronavirus NL63 infection and other coronavirus infections
Dr Bastien is a scientist at the National Microbiology in children hospitalized with acute respiratory disease in Hong Kong,
Laboratory of the Public Health Agency of Canada in Winnipeg. China. Clin Infect Dis. 2005;40:17219.
Her research interests include the diagnosis and pathogenesis of 11. Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. Detection of human
coronavirus NL63 in young children with bronchiolitis. J Med Virol.
respiratory viruses. 2005;75:4635.
12. El Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of
clinical illness in hospitalized patients with common cold virus
References infections. Clin Infect Dis. 2000;31:96100.
13. McIntosh K, Chao RK, Krause HE, Wasil R, Mocega HE, Mufson
1. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell
MA. Coronavirus infection in acute lower respiratory tract disease of
A, Andersson B. Cloning of a human parvovirus by molecular screen-
infants. J Infect Dis. 1974;130:5027.
ing of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102:
14. Van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout
128916.
RJ, Wolthers KC, et al. Identification of a new human coronavirus.
2. Bloom MT, Young NS, 2001. Parvoviruses. In: Knipes DM, Howley
Nat Med. 2004;10:36873.
PM, editors. Fields virology. Philadelphia: Lippincott Williams and
15. Pene F, Merlat A, Vabret A, Rozenberg F, Buzyn A, Dreyfus F, et al.
Wilkins; 2001. p.236180.
Coronavirus 229E-related pneumonia in immunocompromised
3. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol
patients. Clin Infect Dis. 2003;37:92932.
Rev. 2002;15:485505.
4. Collins PL, Chanock RW, Murphy BR. Respiratory syncytial virus.
In: Knipe DL, Howley PM, editors. Fields virology. Philadelphia: Address for correspondence: Yan Li, National Microbiology Laboratory,
Lippincott Williams and Wilkins; 2001. p.144386. Canadian Science Center for Human and Animal Health, 1015 Arlington
5. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact St, Winnipeg, Manitoba R3E 3R2, Canada; email: yan_li@phac-aspc.
of respiratory virus infections on persons with chronic underlying
gc.ca
conditions. JAMA. 2000;283:499505.
Search
past issues
850 Emerging Infectious Diseases www.cdc.gov/eid Vol. 12, No. 5, May 2006